NG2 CAR-T cells

· Shenzhen Geno-Immune Medical Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NG2 CAR-T cells, covering 2025-09-26 to 2025-09-26. Get the full timeline:

Most recent: Clinical Trial Update: NG2 and DLL3 CAR-T Cells Targeting Melanoma [Phase 1, Phase 2]